来源：CTONG会议GOAL AND PURPOSEThe conference will bring you information on the frontiers of clinical and basic research, clinical management and multidisciplinary care. The conference will also.....
[1] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med. 2019 Nov 21.[2] Gefitinib Alone Versus Gefitinib Plus Chemotherapy for NonSmall-Cell Lung Cancer With Mutated Epidermal Gro.....
[1] ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma，Retrieved Janua.....
[1] US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma，Retrieved January 21, 2020, from https://www.prnewswire.com/news-release.....
关注公众号
安卓客户端
